Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Jun;51(2):217-23.
doi: 10.1111/j.1476-5381.1974.tb09650.x.

Can the actions of adrenoceptor agonists and antagonists on pentagastrin-induced gastric secretion be due to their effects of histamine formation?

Can the actions of adrenoceptor agonists and antagonists on pentagastrin-induced gastric secretion be due to their effects of histamine formation?

B P Curwain et al. Br J Pharmacol. 1974 Jun.

Abstract

1 The effects of some adrenoceptor agonists and antagonists which have been reported to affect histamine formation in leucocytes (Assem & Feigenbaum, 1972) have been investigated on gastric secretion in conscious dogs with Heidenhain pouches.2 Submaximal secretion in response to pentagastrin was enhanced by propranolol (0.1-1.0 mg/kg i.v.) and phenylephrine (1.0 mug kg(-1) min(-1) i.v. for 20 min), which increase histamine formation, and was decreased by phentolamine (2 mg/kg i.v.) and isoprenaline (0.05-0.2 mug kg(-1) min(-1) i.v. for 30 min), which decrease histamine formation. Practolol (2 mg/kg i.v.), which has no effect on histamine formation, had no effect on secretion.3 Acid secretion in response to histamine was either unaffected or affected in the opposite direction by these drugs.4 The effects of the drugs on pentagastrin-induced secretion were not secondary to changes in mucosal blood flow (radioactive aniline clearance).5 The results are consistent with the hypothesis that acid secretion in response to pentagastrin involves the formation of endogenous histamine.

PubMed Disclaimer

References

    1. Br J Pharmacol. 1972 Feb;44(2):332P - PubMed
    1. J Physiol. 1956 Sep 27;133(3):498-505 - PubMed
    1. Br J Pharmacol. 1972 Sep;46(1):170-1 - PubMed
    1. Arch Int Pharmacodyn Ther. 1966 Aug;162(2):303-10 - PubMed
    1. Nature. 1972 Apr 21;236(5347):385-90 - PubMed

MeSH terms

LinkOut - more resources